In conclusion, these results reflect that activation of these proteins, RhoA, Rac1 and Cdc42 (phosphorylated forms), were clearly higher in CD4+CD28null T lymphocytes from RA patients in response to IL-15, whereas only RhoA was activated in CD4+CD28+ T lymphocytes. The gene discussed is CD28; the disease is rheumatoid arthritis.